| |
| |
|
| Insider
Information: |
Morgans David J Jr |
| Relationship: |
EVP-Preclinical R&D |
| City: |
Los Altos |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
42,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,265,060 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
42,000 |
|
|
| Total
Value |
$2,265,060 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
EVP-Preclinical R&D |
2009-10-01 |
42,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-08-18 |
4 |
AS |
$6.00 |
$30,000 |
D/D |
(5,000) |
45,000 |
|
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Preclinical R&D |
• – – |
2007-06-29 |
4 |
AS |
$6.00 |
$30,000 |
D/D |
(5,000) |
62,500 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Preclinical R&D |
• – – |
2007-06-15 |
4 |
AS |
$6.46 |
$32,300 |
D/D |
(5,000) |
67,500 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Preclinical R&D |
• – – |
2007-06-15 |
4 |
OE |
$1.20 |
$33,000 |
D/D |
27,500 |
72,500 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-10-13 |
4 |
AS |
$6.67 |
$33,350 |
D/D |
(5,000) |
45,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-06-15 |
4 |
AS |
$6.93 |
$34,650 |
D/D |
(5,000) |
45,000 |
|
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-12-15 |
4 |
AS |
$6.95 |
$34,750 |
D/D |
(5,000) |
45,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-03-15 |
4 |
AS |
$7.01 |
$35,050 |
D/D |
(5,000) |
20,000 |
|
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-09-15 |
4 |
AS |
$7.02 |
$35,100 |
D/D |
(5,000) |
45,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-05-15 |
4 |
AS |
$7.03 |
$35,150 |
D/D |
(5,000) |
20,000 |
|
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-02-15 |
4 |
AS |
$7.18 |
$35,920 |
D/D |
(5,000) |
20,000 |
|
- |
|
| CYTK |
Cytokinetics Inc |
EVP-Preclinical R&D |
• – – |
2009-09-21 |
4 |
AS |
$4.69 |
$36,230 |
D/D |
(7,500) |
52,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-04-17 |
4 |
AS |
$7.34 |
$36,700 |
D/D |
(5,000) |
20,000 |
|
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Preclinical R&D |
• – – |
2007-09-14 |
4 |
OE |
$1.20 |
$38,400 |
D/D |
32,000 |
94,500 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP-Preclinical R&D |
• – – |
2009-10-01 |
4 |
AS |
$5.17 |
$38,975 |
D/D |
(7,500) |
42,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2006-11-15 |
4 |
AS |
$7.80 |
$39,000 |
D/D |
(5,000) |
45,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2007-01-16 |
4 |
AS |
$8.31 |
$41,550 |
D/D |
(5,000) |
45,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2005-11-02 |
4 |
S |
$7.34 |
$93,192 |
D/D |
(12,500) |
22,500 |
|
- |
|
| CYTK |
Cytokinetics Inc |
SVP-Drug Discovery and Dev |
• – – |
2005-11-03 |
4 |
S |
$7.62 |
$176,000 |
D/D |
(22,500) |
0 |
|
- |
|
44 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
